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Background: Reproducible and suitable animal models are required for in vivo experiments to investigate new
biodegradable and osteoinductive biomaterials for augmentation of bones at risk for osteoporotic fractures. Sheep
have especially been used as a model for the human spine due to their size and similar bone metabolism.
However, although sheep and human vertebral bodies have similar biomechanical characteristics, the shape of the
vertebral bodies, the size of the transverse processes, and the different orientation of the facet joints of sheep are
quite different from those of humans making the surgical approach complicated and unpredictable. Therefore, an
adequate and safe animal model for bone augmentation was developed using a standardized femoral and tibia
augmentation site in sheep.
Methods: The cancellous bone of the distal femur and proximal tibia were chosen as injection sites with the
surgical approach via the medial aspects of the femoral condyle and proximal tibia metaphysis (n = 4 injection
sites). For reproducible drilling and injection in a given direction and length, a custom-made c-shaped aiming
device was designed. Exact positioning of the aiming device and needle positioning within the intertrabecular
space of the intact bone could be validated in a predictable and standardized fashion using fluoroscopy. After
sacrifice, bone cylinders (∅ 32 mm) were harvested throughout the tibia and femur by means of a diamond-coated
core drill, which was especially developed to harvest the injected bone area exactly. Thereafter, the extracted bone
cylinders were processed as non-decalcified specimens for μCT analysis, histomorphometry, histology, and
fluorescence evaluation.
Results: The aiming device could be easily placed in 63 sheep and assured a reproducible, standardized injection
area. In four sheep, cardiovascular complications occurred during surgery and pulmonary embolism was detected
by computed tomography post surgery in all of these animals. The harvesting and evaluative methods assured a
standardized analysis of all samples.
Conclusions: This experimental animal model provides an excellent basis for testing new biomaterials for their
suitability as bone augmentation materials. Concomitantly, similar cardiovascular changes occur during
vertebroplasties as in humans, thus making it a suitable animal model for studies related to vertebroplasty.Background
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reproduction in any medium, provided the orpresence of blood flow could significantly alter the risk
of leakage. Animals such as sheep, pigs, goats, calves,
and dogs have been reported as models for several med-
ical problems associated with the human spine [1], in-
cluding bone defects [2] and kyphoplasty [3] in the
lumbar area, although with a high complication rate. For
vertebroplasty in sheep, mostly acute studies (euthanasia
during anesthesia without recovery) were reported with
the focus on cardiovascular complications such as
pulmonary embolus formation. Cement leakage was
followed within the systemic circulation, but notd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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humans [4].
Pulmonary complications similar to those seen in
humans have been described in vertebroplasty studies in
sheep, where percutaneous [5], retroperitoneal [6,7] and
open approaches [8-11] to the lumbar vertebrae were
used. However, the minimally invasive surgical technique
of percutaneous augmentation as commonly used for
treatment of symptomatic vertebral compression frac-
tures in humans, occurring secondary to osteoporosis or
neoplasia [12-19], proved to be difficult to reproduce in
the lumbar vertebrae of sheep. This is primarily due to
the shape of the ovine vertebral body which is quite dif-
ferent and much more difficult to surgically access than
in humans [3,20,21]. Even the standard surgical open ap-
proach to the lumbar area is complicated due to the
large muscle mass in this area, the size of the transverse
processes, the different orientation of the facet joints
and mainly the slim, hour-glass shaped vertebral bodies.
Even under fluoroscopic guidance, inadvertent penetra-
tion of the floor of the spinal canal with subsequent
leakage of material into the dural space are serious com-
plications and major limitations of this model [22]. In
fact, this complication often leads to paraplegia and early
termination of the experiment, although mostly these
complications are never reported in the literature and
only admitted in personal communications. A high per-
centage of the animals have to be euthanized immedi-
ately after recovery due to severe pain and clinical
symptoms often require immediate termination of the
experiments.
Apart from animal welfare reasons (suffering, numbers
of animals used in the experiment), increased costs, high
efforts, and unpredictable outcome necessitate a novel,
simply reproducible and standardized animal model in
sheep. In addition, the animal model preferably should
reproduce the pulmonary complications ranging from
no clinical signs to severe cardiac distress symptoms as
seen in human and ovine vertebroplasty [10,16]. More-
over, a standardized and reproducible evaluation method
to compare results of different studies should be avail-
able. We hypothesized that a femoral and tibial bone
augmentation model in sheep would fulfill all these
criteria.
Methods
Study design and experimental animals
For this novel experimental animal model the relatively
dense cancellous bone of the distal femoral condyle and
proximal tibia metaphysis was chosen as location for
the application of radiopaque augmentation materials. A
customized aiming device was developed that allowed
repeatable, safe and standardized injections under
fluoroscopic guidance.For proof of this animal model 63 adult, female, Swiss
alpine sheep with an average age of 2.7 years (2–5 years)
and a body mass of 70.4 kg (49–99 kg) were used from
consecutive studies focusing on different biomaterial for-
mulations for augmentation (see Table 1). In all sheep,
the same material was injected into the femoral condyle
and proximal tibia of the same limb. Various radiopaque
formulations of biomimetic materials based on a fibrin-
scaffold were tested in comparison to sham controls.
Since this manuscript is dedicated to the description of
the animal model including evaluative procedures, the
details of materials and results of bone enhancement will
be published elsewhere (publication in preparation).
Overall, 12 groups of materials were tested with 5–7 ani-
mals/group (Table 1). As controls sham surgeries were
conducted in 5 sheep.
Due to the low morbidity and invasiveness of the sur-
gical procedure, both hind limbs could be chosen,
resulting in a total of four augmentation sites per sheep
to inject material (n = 252 augmentation sites). For ani-
mal protection and welfare issues, a vertebral augmenta-
tion group as comparison to the new animal model was
omitted due to the expected complications. (In a previ-
ous study in collaboration with an associated research
group using an open and retroperitoneal approach to
the lumbar spine, >80% of the animals had to be eutha-
nized due to complications such as leakage into the
spinal canal and fracture of the vertebral body).
All experiments were conducted according to the
Swiss regulations of Animal Welfare and permission was
granted by the local federal authorities (application # 7/
2008).
The animals were acclimatized to the new environ-
ment approximately 2 weeks before surgery. A pre-
anesthetic examination was performed including general
clinical examination, hematology and chemscreen. Food
was withdrawn 24 h before induction of anesthesia,
while water was available ad libitum.
Animal model
Instruments/equipment
In addition to the routinely used surgical instruments, a
custom-made-aiming device was developed in order to
increase reproducibility of surgical access and to
standardize the injected area. The C-shaped aiming de-
vice allows exact positioning at the medial and lateral
aspects of the tibia or femur including drilling in a given
direction and at a predictable length (Figure 1). The
aiming device consisted of two arms. The distance be-
tween the arms could be adjusted in order to fit the
lateromedial axis of the stifle. A sharp tip is mounted ax-
ially on one arm while a concentric outer tube with
sharp teeth is positioned on the other arm. The aiming
device has to be placed with the tube for the drill hole at
Table 1 Group distribution and CT analysis
Group Number of animals Material CT Clinical signs of pulmonary embolism
1 6 FS +MP1 + CA, with/without BM4 1 1
2 7 FS + CA, with/without BM4
3 5 control/sham 2
4 6 FS +MP2 + CA, with/without BM4
5 6 FS +MP2 + CA, with/without BM4
6 6 FS + CA, with/without BM4
7 5 FS + MP2 + BM1 5
8 5 FS + MP2 + BM2 4
9 5 FS + MP2 + BM3 4 1
10 2 FS + MP2 + BM4
11 5 FS + MP2 + BM5 2 1
12 5 FS + MP2 + BM6 1 1
Legend:
FS: Fibrin-scaffold.
MP1 or 2: Mineral powder 1 or 2.
CA: Contrast agent.
BM1-6: Biomimetic agent concentration 1-6.
with/without: One leg with and one leg without BM4.
This table shows the group distribution of all animals including the numbers of CT’s performed in each treatment group as well as the numbers of animals with
cardiovascular complications occurring during surgery.
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pect of the tibia or femur (Figure 2a). This positioning of
the aiming device allows the insertion of the drill and ul-
timately the needle relatively parallel to the articular surface
of the femoro-tibial joint. With the concentric tube and the
distal sharp tip being in line, the suggested insertion trajec-
tory for the needle can be validated using fluoroscopy in
mediolateral and craniocaudal view (Figure 2b).Figure 1 C-shaped aiming device. This photograph shows the c-shaped
concentric outer tube with sharp teeth (a) and a mountable sharp tip (b) f
subsequently a 10G-vertebroplasty needle (needle (d), handle (e), and styleFor the injection of augmentation material, a 10G
(3.2 mm diameter) 100 mm-long special vertebroplasty
needle (1394–1010, Optimed Medizinische Instrumente
GmbH, Ettlingen, Germany) and an Optimed CementoRE
gun (1392–0000, Optimed Medizinische Instrumente
GmbH, Ettlingen, Germany) were used. The vertebroplasty
needle consisted of three parts, needle, handle, and stylet
(Figure 1).aiming device consisting of two adjustable arms with a mountable
or device fixation. For application of biomaterial, a drill (c) and
t (f)) were applied through the arm with the concentric tube (a).
a b 
Figure 2 Correct placement of the aiming device. The aiming device was placed with the tube for the needle at the medial aspect and the
sharp tip fixed on the lateral aspect of the tibia (a). Fluoroscopy pictures were used to validate correct placement of aiming device and needle as
well as subsequent material injections (b).
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Animals were premedicated intramuscularly with
buprenorphine (Temgesic®, 0.01 mg/kg, Essex Chemie
AG, Lucerne, Switzerland) and xylazine (Rompun® 2%,
0.1 mg/kg im, Streuli Pharma, Uznach, Switzerland).
After approximately 30 minutes, a catheter (Vygonyle S®
G14, Vygon GmbH, Aachen, Germany) was placed into
one jugular vein and prophylactic antibiotics (Penicillin
Natrium® 35′000 IU/kg i.v.; G. Streuli Pharma, Uznach
Switzerland; gentamicin, Vetagent®, 4 mg/kg i.v.,
Veterinaria AG, Zurich, Switzerland) as well as a pre-
emptive analgesic (Rimadyl®, 4 mg/kg i.v.; Pfizer SA,
Zurich, Switzerland) were given intravenously. A
booster for tetanus (tetanus serum Intervet, 3000 IU/
sheep s.c.; Veterinaria AG, Zurich, Switzerland) was
administered subcutaneously. Anesthesia was induced
with diazepam (Valium®, 0.1 mg/kg i.v., Roche Pharma
AG, Rheinach, Switzerland), ketamine (Narketan 10®,
2 mg/kg i.v., Vetoquinol AG, Belp-Bern, Switzerland)
and propofol (Propofol®, 0.4-2 mg/kg iv, Fresenius
Kabi, Stans, Switzerland) administered to effect.
After laryngeal desensitization with lidocain spray
(Xylocaine Spray 10%, 3 pumps of 0.1 mL, Astra
Zeneca AG, Zug, Switzerland), the trachea was
intubated and correct placement was confirmed by ex-
pired carbon dioxide monitoring (FetCO2). Anesthesia
was maintained with a balanced anesthetic protocol
employing administration of isoflurane (1-2%vol) in
oxygen via an adult F-circuit (circle system, Intersurgical,
Berkshire, UK) and a constant rate infusion of propofol
(Propofol®, 0.5-1 mg/kg/h, Fresenius Kabi, Stans,
Switzerland). All animals received intravenous fluids
throughout the procedure (Ringer solution, 10 mg/kg/
h). Cardiovascular monitoring parameters included
electrocardiogram (ECG), heart rate, pulse rate and
invasively measured blood pressures (systolic, mean
and diastolic arterial) via an arterial catheter in an
auricular artery.Surgical procedure
The anesthetized sheep were placed in dorsal recum-
bency tilted at a 30° angle to the non operated side, with
the hind limb slightly flexed and fixed at the surgery
table. For the second leg repositioning was required.
Aseptic preparation of the surgical field was performed
routinely.
Two small incisions (1 cm) were performed at the
medial aspect of the femoral condyle (directly above the
femoral epicondyle) and at the metaphysis of the prox-
imal tibia (at the distal end of the collateral ligament).
Soft tissue was dissected down to the bone and the
aiming device was placed with the tube for the drill hole
at the medial aspect and the sharp tip fixed on the lat-
eral aspect of the tibia or femur (Figure 2a). For fixation
of the sharp tip on the lateral side only two stab
incisions of the skin were needed, at the same level as
the medial ones. Bleeding was controlled using an
electrocautery.
Using fluoroscopy in two projection planes (mediolateral
and craniocaudal), the right position of the aiming device
and subsequent needle positioning could be validated and
inaccurate injections avoided.
A drill hole with a diameter of 2.7 mm was created
and followed by placing the special vertebroplasty needle
with the tip ending in the trabecular portion of the fem-
oral condyle (in parallel direction to the stifle joint sur-
face) or proximal tibial bone (in slightly oblique
direction to the fibula head).
The material injections were done in multiple steps
under fluoroscopic guidance. Needle filling with bio-
mimetic material was done slowly with the aid of the
Optimed CementoRE gun (Figure 3). Subsequently, the
gun was removed and a stylet was used to push the ma-
terial through the needle into the bone, so as to provide
exact quantities of injectate. If necessary a hammer was
used to push the stylet and the material into the bone.
The filling-clearing procedure was repeated three or four
a b
Figure 3 Injection procedure. Injections were performed with an Optimed CementoRE gun (a) and made in multiple steps under fluoroscopic
control (b).
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intertrabecular space. Using fluoroscopy, leakage of the
material into a vessel and thrombus formation was
recorded and the amount of that material was estimated
and documented.
Sham operations consisted of drilling and placing the
needle as described above. The stylet was then inserted
and removed three times without material injection.
At completion of the injection procedure, the
vertebroplasty needle and the aiming device were re-
moved and the insertion point was closed with a
3.5 mm diameter self-tapping screw (10 mm in length,
Synthes, Oberdorf, Switzerland). The screw was used
to determine the insertion point and the direction of
the needle after sacrifice.
Closure of subcutaneous tissue was routinely done using
resorbable suture material (Vicryl® 2–0, Johnson & Johnson
Int., Brussles, Belgium) in a continuous fashion, while the
skin was closed with a skin stapler (Appose ULV, United
States Surgical). No further external stabilization was used.
After repositioning, the augmentation procedure of
the contralateral limb was performed in identical man-
ner. Immediately after surgery lateral and craniocaudal
fluoroscopy images were taken to document the
distribution of the injected material in two projection
planes.Postoperative treatment
After surgery and recovering from anesthesia, the ani-
mals were kept in small groups and their health status
was checked twice daily. Food and water were offered ad
libitum. Antibiosis and analgesia administrations were
continued via the jugular catheter for 4 days using the
same dosages as perioperatively applied. In addition,
buprenorphine injections i.m. were continued every
4 hours for two applications to reduce postoperative
pain.
After 21 days the staples were removed and the
animals were released to pasture.Fluorescence labelling
For a dynamic representation of new bone formation
and remodeling, different fluorescence markers were
subcutaneously injected at different time points. Calcein
green (1 ml/kg s.c.; Fluka AG, Buchs, Switzerland) was
applied after 4 weeks, xylenolorange (1 ml/kg s.c.; Fluka
AG) three days before sacrifice.Evaluation
Computer Tomography Angiography
Computer Tomography Angiography (CTA) of the
thorax was performed in 19 sheep either after cardiovas-
cular complications developed during surgery indicating
pulmonary embolism or in selected cases to visualize the
potential occurrence of pulmonary embolism caused by
bone marrow/fat particles or material deposition. The
CT study was performed with a multi-row unit using 40
rows, slice collimation of 0.6 cm and a pitch of 1. The
contrast medium dose was 700 mg/kg of an iodinated
high-osmolar contrast medium (Telebrix®, 350 mgI/ml,
Guebert, Zurich, Switzerland). The volume of embolized
material was calculated using an automated region of
interest propagation technique with an upper attenu-
ation threshold of 5000 Hounsfield units (HU) and lower
threshold of 300 HU.Specimen preparation for evaluative procedures
After sacrifice, the tibia and femur were extracted for
final analysis. Augmentation sites were examined macro-
scopically and digital pictures were recorded (Nikon
Digital Camera D5000, © 2009 Nikon Corporation). Sub-
sequently the bones were radiographed using a Faxitron
(Faxitron X-Ray Systems; Hewlett Packard, Mc Minnville
Division, OR) to visualize the detailed bone structure
and detect remaining augmentation material.
To provide a standardized evaluation process, an ap-
propriate harvesting method was designed to locate the
area of interest for histological evaluation.
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pointer into the head of the screw, the original direction
of the injection needle could be established (Figure 4a).
The bone was fixed to the drill press table with a
custom-made universal joint holder. By manipulating
the holder, the appropriate position could be found by
ultimately aligning the original direction of the injection
needle with the central axis (Figure 4b) of the drill press.
After screw and pin pointer removal, the 32 mm diam-
eter, water-cooled diamond core drill was mounted on
the drill press and an accurate bone cylinder was cored
with the original needle path matching the axis of the
cylinder (Figure 4c). A mark was made with a band saw
on the cortical bone from the entry point of the needle
in distal direction. This allowed consistent positioning of
the sample for μCT scanning and served as a reference
for the cutting of the histology slices.
All bone samples were fixed in 40% ethanol for 1 week,
followed by a series of ethanol dehydration (50-100%)
within 6 days. Once the specimens were fixed in 70%
ethanol, μ-CT analysis was performed by b-cube AG
(Bio-Technopark, Schlieren-Zurich, Switzerland).a b 
c 
Figure 4 Harvesting method. To provide a standardized evaluation proce
was designed: Using a custom-made screw the original direction of the ne
of the bone to a drill press table aligning the original needle path with the
marks the pin pointer used for defining the drill axis. After screw and pin p
32 mm diameter bone cylinder was cut (c). The black line in Figure c mark
point and needle path in the center.After μ-CT analysis and complete dehydration all sam-
ples were degreased in xylene and subsequently infil-
trated in liquid polymethylmethacrylate (PMMA).
Polymerization was carried out in plastic molds closed
with a lid and kept at 4°C for 1 week, thereafter in a
water bath at room temperature until polymerization
occurred. Finally the plastic molds were placed in an
incubator (37°C) uncovered to complete hardening of
the samples.
Ground sections (300 μm) and native fluorescence sec-
tions (350 μm) were cut using a special band saw
(EXAKT® Band System 300/301, EXAKT® Apparatebau
GmbH &Co KG, Norderstedt, Germany). The blocks
were cut lengthwise the needle path. The needle path,
the tip of the needle, and surrounding tissue defined the
region of interest. Before mounting (Cementit® CA 12,
Merz + Benteli AG, Niederwangen, Switzerland) the
sections on plastic slides (ACROPAL, Maagtechnic,
Duebendorf. Switzerland), microradiographs were taken
in the Faxitron (27 kV, 11 s; Fuji Photo Film Co Ltd,
Tokyo, Japan). Ground sections were polished (Exakt®
Mikro- Schleifsystem 400CS, Exakt Apparatebau GmbH,ss and locate the area of interest, an appropriate harvesting method
edle could be established (a). A custom-made holder allowed fixation
axis of a diamond-coated water-cooled core drill (b). The black arrow
ointer removal, the core drill was mounted on the drill press and a
s the cutting mark for histology sections with original needle insertion
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dine blue. The native sections for fluorescence were
mounted on pellucid, acrylic plexiglas slides (Maagtechnic,
Duebendorf, Switzerland) and wrapped in aluminium foil
to protect slides from bleaching.
For the thin sections the area of interest of the
remaining bone blocks, comprising the tip of the needle
and surrounding tissue, was cut into a smaller segment
and polymerized in special customized Teflon forms
(D. Nadler, JOSSI AG, Islikon, Switzerland) at room
temperature. For hardening, the teflon forms were put
in the incubator at 37°C. Thereafter, blocks were
mounted on plastic frames and cut using a microtome
(Leica® RM 2155, Leica Instruments GmbH, Nussloch,
Germany). After placing the sections on glass slides, they
were deplastified with Methoxyethyl-acetate (Merck AG,
Switzerland) and stained with either toluidine blue or
von Kossa/McNeil.
Histological evaluation
The standardized cutting procedure of all samples along
the original needle path ensured comparability of the re-
sults obtained for the different treatment groups. The
area around the tip of the original needle, where most of
the augmentation material was injected, was identified
as region of interest for analysis.
Ground sections were evaluated histomorphometrically
(Leica Qwin®, Leica Quips®, Leica, Glattbrugg, Switzerland)
to quantify the percentages of new bone, old bone,Figure 5 Histomorphometrical evaluation. Histomorphometry was used
and residual augmentation material within the area of interest. For standar
chosen around the tip of the needle. Cortical bone area was excluded from
considered as 100%. Circles including growth plate were completely excludgranulation tissue, and residual augmentation material
within the area of interest.
First, the ground sections were captured with the
macroscope (Leica Z6 APOA, Leica DFC 420C, Glattbrugg,
Switzerland) as digital images in TIF-format using a 5.6-
fold magnification. To standardize the evaluated area four
circles of 6 mm in diameter were chosen around the tip of
the needle (Figure 5). If the circles contained cortical bone
it was excluded from the region of interest, since more old
bone with high density is present in the cortex. The rest of
the circle was considered as 100%. Circles including the
growth plate were excluded from the analysis, since a
higher rate of new bone was present independently of the
applied material.
Thin sections were semi-quantitative evaluated using
a microscope (Leica® DMR, Glattbrugg, Switzerland) in
a ten-fold magnification. Scores were given for pres-
ence of macrophages, mononuclear cells, osteoclasts,
multinucleated foreign body cells, debris of bone, isles
of not calcified osteoid, agglomeration of mononuclear
cells, percentage of osteoid seam, osteoid thickness,
and material in bulk. Three power fields per section
were assessed with two peripheral and one central in
the injected area. For macrophages, mononuclear cells,
and fibroblasts scores were given in percentages of
cells per power field (0 = 0%; 1 = 1-25%; 2 = 26-50%; 3
>50%). For multinucleated foreign body cells and oste-
oclasts absolute numbers were counted per power field
(0 = 0; 1 = 1-5; 2 = 6-10; 3= >10 cells).to quantify the percentage of new bone, old bone, granulation tissue,
dization of the evaluated area four circles of 6 mm in diameter were
the analysis (black area in circle 1). The rest of the circle was
ed from the analysis (circle 3 + 4).
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tion with a special fluorescence microscope equipped
with different filters appropriate for the used dyes (Leica®
DM 6000B, Leica Microsystems CMS GmbH). To
achieve one adequate picture including the whole area
of interest centered at the tip of the needle, 30 images had
to be taken and merged together to one using a compatible
camera (Leica®DFC 350 FX, Leica Microsystems CMS
GmbH, Mannheim, Germany) and a specific merging
software (Leica® Microsystems CMS GmbH, Mannheim,
Germany).
Focus was placed on differences of dye integration be-
tween groups as well as at different time points (calcein
green at 6 and xylenol orange at 12 weeks).
A semiquantitative evaluation of the recorded images
was performed scoring the percentage of each fluores-
cent dye in the area of interest (considered as 100%) (0
= 0%; 1 = 1-25%, 2 = 26-50%, 3= >50%).Micro CT evaluation
All samples were measured with a micro-computed tomog-
raphy system (μCT 40, Scanco Medical AG, Brüttisellen,
Switzerland). Semiautomatic masks of sphere shells in dif-
ferent sizes were performed centered at the original pos-
ition of the tip of the needle to evaluate bone volume
density and trabecular thickness of these spheres as well as
the residual radiopaque material. To measure only the tra-
becular bone area, the needle path and the cortical bone
were excluded from the analysis.Results
Animal model
A total of 63 sheep were treated with the tibia and femur
augmentation model. Sixty-two sheep completed the
12 weeks follow-up period successfully. One animal had
to be euthanized 6 weeks after surgery due to the pres-
ence of a malignant lymphoma in the wall of the urinary
bladder, unrelated to the study treatment.
Augmentation could be achieved successfully in all 63
animals and after a learning curve initially 245/252 aug-
mentation sites were highly reproducible and without
complication. In 7/252 needle positioning problems oc-
curred (see below). The overall surgical procedure for
each hind limb was between 30–40 minutes. In addition,
the minimally invasive surgical procedure led to immedi-
ate recovery and minimal physical stress. After a short
recovery period due to anesthesia (e.g. 30 minutes), the
sheep rose and moved around without lameness. During
the 12 weeks follow up, no signs of inflammation,
wound infections, lameness or other discomfort were
noticed in any of the 62 remaining sheep. Furthermore,
the sheep exhibited no pain response following palpation
of the injected sites.The surgical technique using the aiming device and
fluoroscopic imaging were particularly useful to inject
the material into a standardized anatomical location.
Under fluoroscopic guidance during surgery, it could
also be verified that consistent amounts of biomaterials
were injected into the trabecular bone and distributed in
a sphere-like shape around the tip of the needle. This
distribution and needle placement could also be verified
using the evaluative procedures. μCT images, microra-
diographs, indicated very consistent and standardized in-
jection areas (see below).
Due to the high density of the trabecular bone at the
injection site, the needle could not be introduced with
manual pressure as it is described in human medicine.
Instead, a hole was drilled and the needle pushed into
the trabecular bone by using a mallet. As mentioned
above, needle-positioning problems occurred in only 7/
252 injection sites. In two of these cases, the needle dir-
ection was slightly different than the original drilling
path resulting in a second hole at the tip of the needle,
although without associated complications. In the
remaining five of these seven cases, the needle position-
ing was assumed to be in the correct place based on
fluoroscopy. However, upon injection a small amount of
the biomaterial was identified within the joint space in
two cases and within the periarticular soft tissues in
three cases. When leakage of material was discovered,
the reposition of the needle was attempted in order to
inject in the predefined area. In three cases there was no
additional leakage during the following injection. In two
cases the injection was cancelled due to persistent leak-
age during the additional attempts.
To inject the augmentation material along the small
diameter of the vertebroplasty needle into the dense
intertrabecular bony space, high injection pressure was
necessary. During the injection procedure the viscosity
of the augmentation materials increased depending on
the duration of the procedure. For the second and third
injection of each augmentation site, a mallet was re-
quired to cautiously push the stylet and force the mater-
ial along the needle into the bone.
The radiopaque materials were visualized without
problems during injection in 208 augmentation sites. In
24 injection sites of 6 sheep of the same group, the ma-
terial could not be identified with fluoroscopy due to in-
adequate radio-opacity of the augmentation material.
This augmentation material was considered not suitable
for injections under fluoroscopic control. In the 20 sham
control sites (5 sheep) no material was actually injected
and thus, could not be visualized. Leakage of augmenta-
tion material was observed in 90 out of 208 injections
(43.3%). No differences between the various materials
could be allocated. Out of those 90 cases, leakage into
the venous circulation occurred in 54 injections (26%),
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in 31 injections (14.9%). Leakage into the periarticular
soft tissues was detected in 5 additional cases (2.4%). A
higher number of leaks during the injection procedure
occurred in the tibia (60%) than in the femur (40%), es-
pecially for the second and third injections at the injec-
tion sites where higher pressure had to be applied for
injection. Despite the high number of biomaterial leaks
observed with fluoroscopy, no clinical symptoms indica-
tive of cardiovascular and/or pulmonary distress were
recorded in 59 sheep (93,7%). In four animals, cardiovas-
cular complications occurred during surgeries including
sudden decrease in arterial blood pressure and end-
expired CO2 by approximately 50%. In those four
animals, CT angiography of the thorax revealed
embolization with augmentation material and bone
marrow, and fat particles. All four animals recovered
without additional complications and completed the 12-
week follow up successfully. Based on this experience, a
randomized and prophylactic CT analysis of subsequent
15 sheep was performed, which demonstrated lung
embolization in 13/15 animals undergoing augmentation
with injection of biomaterial. In the other two animals (2/
15), which belonged to the control group, no embolization
was found. Out of the 17 sheep treated with augmentation
material and demonstrating embolization, 7 sheep (41.2%)
showed embolism caused by bone marrow and fat particles
as well as material deposition, while 10/17 sheep (58.8%) re-
vealed embolism due to material only. Overall 202 emboli
were found in 17 sheep treated with augmentation material.
They occurred in the majority of the cases in the
subsegmental artery within the lung vasculature, for bone
marrow respectively fat particles (12 emboli) and material
(156 emboli), but there were emboli in the segmental (6 fat
emboli/24 material emboli) as well as in lobar artery (1 fat
emboli/3 material emboli), although in lower incidence
with the latter.
Another surgical complication was the breaking of the
needle during the extraction procedure from the bone.
The needle broke, or rather dismantled at the glued
junction between needle and handle. In 4 of 14 cases,
the broken part of the needle could not be removed and
remained in the bone so that the insertion of the self-
tapping screw was not possible. However, no further
complications resulted from this event, although the ab-
sence of the screw made the coring procedure after sac-
rifice less precise, and all bone cylinders contained the
entire area of interest.
Evaluation
The harvesting process of the tibia and femur at sacrifice
were uneventful. μCT, microradiography, and histology
were excellent tools to verify needle placement and ma-
terial distribution within the local anatomic sites. On theone hand, material deposition was still visible and on the
other hand bone remodeling alongside the original drill
hole and the tip of the needle clearly identified the
location.
Due to early termination of one sheep, only 248
samples were further processed for evaluation. The
harvesting process itself, in terms of drilling the 32 mm
bone cylinder and preparing the area of interest for
evaluation, proved to be reproducible and guaranteed a
highly standardized analysis in 243/248 samples. Three
out of 248 samples had to be excluded from the histo-
logical evaluation since the tip of the needle was not
centered in the cylinder so that the ground sections were
cut in the wrong layer. In the other two, no injection
was performed due to needle positioning problems. All
other samples could be embedded, cut and prepared for
analysis without further complications.
Needle placement could be visualized in the μCT im-
ages due to the fact that the original needle path was not
yet healed. μCT confirmed the suitability of the surgical
method with respect to the consistent placement of the
needle in the desired trabecular bony space. Due to the
presence of an open physis in the proximal tibia in some
animals, the injection resulted in deposition of biomim-
etic material in the trabecular bone within the physis, in
the epiphysis or in the metaphysis (Figure 6). In con-
trast, injections in the femur resulted in consistent de-
position of augmentation material within the distal
femoral epiphysis. The μCT evaluation of the control
animals showed a relatively high bone volume density
(Bone volume/total volume) with thick trabeculae for
both, the femora and the tibiae with a 10% higher bone
volume density for the tibia metaphysis (approx. 35%)
than for the femora (approx. 25%).
With the microradiograph images of the ground sec-
tions, the stage of calcification of the bone samples
within the area of interest and adjacent to remaining
biomaterial could be identified as too could the original
and standardized needle positioning (Figure 7). While
the ground sections were well suited for the assess-
ment of new bone formation, material resorption, and
histomorphometrical measurements (Figure 8a), thin
sections enabled distinctions to be made between
cellular reactions such as osteoblast activation, inflam-
matory responses or degradation and elimination of
biomaterials through macrophages (Figure 8b, c).
The fluorescence sections represented the area of bone
activity at six weeks post surgery (Figure 9a, green col-
ours) and at twelve weeks post surgery (Figure 9b, red
colors) and demonstrated the sphere-like shape distribu-
tion of the biomaterial. A less colored area was observed
in the middle of the injected region, corresponding to
the biomaterial degradation process followed by a red
and a green area towards the periphery. This pattern
a 
b 
c 
Figure 6 Micro-CT images. Micro-CT images confirmed the
suitability of the surgical method with respect to the consistent
placement of the needle in the desired trabecular bony space. Due
to the presence of an open physis in the proximal tibia in some
animals, the injection resulted in deposition of biomimetic material
in the trabecular bone within the epiphysis (a), the physis (b), or in
the metaphysis (c).
Figure 7 Microradiograph image. This figure shows a
microradiograph image of a ground section: Stage of bone
calcification in the area of interest and adjacent to remaining
biomaterial could be shown.
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biomaterial was being degraded from the periphery to-
wards the center of the injected region (Figure 9).
Discussion
In our study, a femoral and tibial bone augmentation
model was successfully established and validated using
63 sheep as an alternative to vertebroplasty in the lum-
bar area of sheep. In comparison to the lumbar
vertebroplasty procedures in sheep, the femoral-tibialaugmentation model proved to be safe, easy and quick
to apply, and additionally showed a high level of
standardization including the harvesting of core samples
for histology and the histology evaluation. The surgical
procedure was limited to 30–40 minutes per side, which
was significantly shorter than pilot studies (unpublished
data) with lumbar vertebral augmentation in sheep,
which lasted for several hours. More importantly, the
procedure eliminated severe complications (massive
spinal cord injuries) and reduced animal pain and suffer-
ing. Moreover, the animal model proved to be adequate
to study pulmonary embolism and systemic changes as
sequelae to vertebroplasty as they occur in humans.
The animal model presented served well to evaluate
new biomimetic materials for their osteoinductive,
osteoconductive, and degradation properties as bone
augmentation materials. The advantage was that the
test-materials could be injected with high accuracy and
repeated success within the inter-trabecular spacing of
the intact femoral condyle and proximal tibia. This sur-
gical technique required a specially developed aiming
device and fluoroscopic imaging. Both are also required
for (percutaneous) vertebroplasty in humans. The appli-
cation and visualization of the injected material in the
region of the stifle joint in sheep is much easier com-
pared to the lumbar area, where visualization is impaired
by overlying structures (intestines, rumen, transverse
processes, etc.). The absence of the third plane using
two-dimensional fluoroscopy has to be taken into con-
sideration during needle positioning and injection pro-
cedure to avoid injections out of the predefined area,
which occurred only in 5/252 needle placements. Solid
knowledge of how the trabecular area is distributed
within the proximal tibia and experience of the surgeon
helps to avoid injections into the bone marrow and/or
a 
b 
c 
Figure 8 Histology samples. Ground sections (approx. 300 μm,
surface stained with toluidine blue) were well suited for assessment
of new bone formation, material resorption and
histomorphometrical evaluation (Figure a), while thin sections
allowed assessment of cellular reactions e.g. osteoblast activation
(Figure b, c, thin black arrows) and biomaterial degradation through
macrophages (Figure b, c, thick white arrows).
a 
b 
c 
Figure 9 Fluorescence section. These fluorescence images show
the bone activity grade at two different time points according to
the integrated fluorescent respectively. Figure a shows the activity
grade at 6 weeks post op (Calcein green), Figure b at 12 weeks post
op (Xylenol orange), and in Figure c both time points are merged
together to one image.
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the needle.
When comparing the results of Hildebrand et al. [23]
retrieved from human bone samples with those of Rubin
et al. [24] from sheep bone, it becomes evident that tra-
becular bone density is much higher in sheep than in
human bone. This comparison of previous findings of
other research teams is in alignment with the results of
our study presented here. Hildebrand et al. measured
for samples of lumbar human spine (2. and 4. vertebra) a
low bone volume density (8-9%) with small trabeculae,whereas in the current augmentation sheep study bone
volume densities between 25-35% for tibiae and femura
and even higher values in the study of Rubin et al. for
medial femoral condyles (49.1 ± 7.1%). This high bone
density and thick bone trabecula make the needle place-
ment and the injection procedure more challenging in
sheep (personal surgical experience). To place the needle
for percutaneous VP in the osteoporotic, brittle human
bone, it only has to be tapped with a mallet to engage
the cortical bone and afterwards can be pushed forward
Klein et al. BMC Musculoskeletal Disorders 2013, 14:200 Page 12 of 13
http://www.biomedcentral.com/1471-2474/14/200with manual pressure into the right position [25]. In
contrast, in sheep, a hole had to be drilled first to be able
to push the needle forward into the trabecular bone with
the aid of a mallet. This procedure weakened the needle
and caused breakage at the glued junction between nee-
dle and it’s handle during the extraction procedure of
the needle in 14 cases. Due to the fact that the needle
could not be extracted in only four cases, and no further
complication resulted from this event, the needle type
was not changed during this study. For future studies,
the use of another type of needle, e.g. with a melted
junction (not commercially available at the moment)
could be taken into consideration to avoid needle
breakage.
During the injection procedure, the viscosity of the
augmentation materials increased depending on the dur-
ation of the procedure. As such, forced injections under
high pressure using a mallet were often necessary for the
second and third injections of each injection site along
the small diameter of the vertebroplasty needle into the
dense intertrabecular bony space of the tibial and fem-
oral bone. This could have led to a higher risk for mater-
ial extravasation as well as bone marrow and fat
particles being forced out into the systemic circulation.
The higher percentage of material leakage detected in
the tibia as compared to femur, could be explained by
the approximately 10% higher trabecular bone density
and thicker trabeculae in the proximal tibia metaphysis
than in the femoral condyle, which may have produced
higher resistance to the augmentation material. Pulsed
jet-lavage of bone marrow and fat was reported to
improve injection and lessen the risk of emboli [26].
However, in our hands it did not facilitate injection in
a preliminary study and therefore, the fragmented
injection technique was invented and applied through-
out the study. Although it may not completely mimic
vertebroplasty in osteoporotic human bone, it may be
considered close enough to test substances in sheep for
later use in human bone. During vertebroblasty in
humans, leakage of bone cement is also reported as the
most common complication [25,27]. Therefore, this ani-
mal model could provide important information about
the material properties if leakage occurs during the in-
jection procedure. Due to the absence of chest radio-
graphs or CTs after vertebroplasty on asymptomatic
human patients, cement leakage and pulmonary emboli
occurrence secondary to vertebroplasty may often be
underestimated [16]. In the presented study in sheep,
CT angiography of 19/63 sheep revealed a high number
of asymptomatic pulmonary emboli (13/19 sheep =
68.4%) confirming the opinion of Hulme et al. that CT
is the best method to detect cement leakage and should
be used to report all leaks, including those without
clinical signs [16,28,29].Another consequence of the forced injections of aug-
mentation material was microdamage and microfracture
of trabecular bone, which occurred centrally to the
injected area, and could be seen in the histology sections
as well as in the fluorescence sections. This trabecular
damage may be less in human osteoporotic bone due to
reduced bone quality and quantitiy (wider trabecular
spaces). Alternatively the diminished bone quality may
also facilitate microfractures within the trabecular struc-
ture, thus resulting in a similar situation as encountered
in sheep. Since osteoporotic bone is weaker, but not im-
paired in proliferation [30], remodeling activities may be
similar to those present within our sheep model. As a
consequence, a resorption zone around the injected area
developed in some cases unrelated to the injected mater-
ial itself.
Conclusions
This tibia and femur augmentation sheep model proved
to be a suitable animal model for screening studies of
new biomaterials intended for bone augmentation of tra-
becular bone and enabled analysis of their biodegradable,
biocompatible and osteoconductive properties. It also
proved to be adequate for the study of the sequelae of
material leakage into the circulation, e.g. pulmonary em-
bolism and following cardiovascular changes.
Overall, we consider it a safe model for the experi-
enced surgeon, resulting in reduced animal suffering and
could serve as an excellent basis for testing bone indu-
cing or enhancing materials for vertebroplasty.
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